company background image

Valiant Organics NSEI:VALIANTORG Stock Report

Last Price


Market Cap







07 Aug, 2022


Company Financials +
VALIANTORG fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance2/6
Financial Health3/6

VALIANTORG Stock Overview

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India.

Valiant Organics Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Valiant Organics
Historical stock prices
Current Share Price₹618.55
52 Week High₹1,664.95
52 Week Low₹504.00
1 Month Change16.66%
3 Month Change-25.38%
1 Year Change-53.02%
3 Year Changen/a
5 Year Changen/a
Change since IPO-58.04%

Recent News & Updates

Shareholder Returns


Return vs Industry: VALIANTORG underperformed the Indian Chemicals industry which returned 8.7% over the past year.

Return vs Market: VALIANTORG underperformed the Indian Market which returned 7% over the past year.

Price Volatility

Is VALIANTORG's price volatile compared to industry and market?
VALIANTORG volatility
VALIANTORG Average Weekly Movement8.5%
Chemicals Industry Average Movement6.5%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.3%

Stable Share Price: VALIANTORG is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: VALIANTORG's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

1984841Arvind Chheda

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and para nitroaniline. The company’s products also comprise ortho chloro para nitro aniline, 6 acetyl OAPSA, OA acetanilide, and PA acetanilide; ortho anisidine, para anisidine, ortho toluidine, para toluidine, IPPCA, FI aniline, and meta chloro aniline; acids; para and ortho amino phenol; and ortho and para nitro anisole.

Valiant Organics Fundamentals Summary

How do Valiant Organics's earnings and revenue compare to its market cap?
VALIANTORG fundamental statistics
Market Cap₹16.80b
Earnings (TTM)₹1.02b
Revenue (TTM)₹11.76b


P/E Ratio


P/S Ratio

Is VALIANTORG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
VALIANTORG income statement (TTM)
Cost of Revenue₹8.05b
Gross Profit₹3.71b
Other Expenses₹2.69b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Aug 08, 2022

Earnings per share (EPS)37.59
Gross Margin31.55%
Net Profit Margin8.68%
Debt/Equity Ratio55.9%

How did VALIANTORG perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is VALIANTORG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VALIANTORG?

Other financial metrics that can be useful for relative valuation.

VALIANTORG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA10.7x
PEG Ratio0.4x

Price to Earnings Ratio vs Peers

How does VALIANTORG's PE Ratio compare to its peers?

VALIANTORG PE Ratio vs Peers
The above table shows the PE ratio for VALIANTORG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average10.7x
524667 Savita Oil Technologies
506852 Punjab Alkalies & Chemicals
500655 Garware Hi-Tech Films
500052 Bhansali Engineering Polymers
VALIANTORG Valiant Organics

Price-To-Earnings vs Peers: VALIANTORG is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the peer average (10.7x).

Price to Earnings Ratio vs Industry

How does VALIANTORG's PE Ratio compare vs other companies in the IN Chemicals Industry?

Price-To-Earnings vs Industry: VALIANTORG is good value based on its Price-To-Earnings Ratio (16.5x) compared to the Indian Chemicals industry average (18.6x)

Price to Earnings Ratio vs Fair Ratio

What is VALIANTORG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VALIANTORG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.5x
Fair PE Ratio31.4x

Price-To-Earnings vs Fair Ratio: VALIANTORG is good value based on its Price-To-Earnings Ratio (16.5x) compared to the estimated Fair Price-To-Earnings Ratio (31.4x).

Share Price vs Fair Value

What is the Fair Price of VALIANTORG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VALIANTORG (₹618.55) is trading above our estimate of fair value (₹50.76)

Significantly Below Fair Value: VALIANTORG is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Valiant Organics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score


Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VALIANTORG's forecast earnings growth (40.8% per year) is above the savings rate (6.8%).

Earnings vs Market: VALIANTORG's earnings (40.8% per year) are forecast to grow faster than the Indian market (18.4% per year).

High Growth Earnings: VALIANTORG's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: VALIANTORG's revenue (20.2% per year) is forecast to grow faster than the Indian market (10.8% per year).

High Growth Revenue: VALIANTORG's revenue (20.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VALIANTORG's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Past Performance

How has Valiant Organics performed over the past 5 years?

Past Performance Score


Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: VALIANTORG has high quality earnings.

Growing Profit Margin: VALIANTORG's current net profit margins (8.7%) are lower than last year (13.7%).

Past Earnings Growth Analysis

Earnings Trend: VALIANTORG's earnings have grown significantly by 23.6% per year over the past 5 years.

Accelerating Growth: VALIANTORG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: VALIANTORG had negative earnings growth (-12.4%) over the past year, making it difficult to compare to the Chemicals industry average (21.8%).

Return on Equity

High ROE: VALIANTORG's Return on Equity (17.9%) is considered low.

Discover strong past performing companies

Financial Health

How is Valiant Organics's financial position?

Financial Health Score


Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: VALIANTORG's short term assets (₹5.2B) exceed its short term liabilities (₹4.0B).

Long Term Liabilities: VALIANTORG's short term assets (₹5.2B) exceed its long term liabilities (₹1.3B).

Debt to Equity History and Analysis

Debt Level: VALIANTORG's net debt to equity ratio (48.2%) is considered high.

Reducing Debt: VALIANTORG's debt to equity ratio has increased from 1.2% to 55.9% over the past 5 years.

Debt Coverage: VALIANTORG's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: VALIANTORG's interest payments on its debt are well covered by EBIT (21.5x coverage).

Balance Sheet

Discover healthy companies


What is Valiant Organics's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: VALIANTORG's dividend (0.57%) is higher than the bottom 25% of dividend payers in the Indian market (0.39%).

High Dividend: VALIANTORG's dividend (0.57%) is low compared to the top 25% of dividend payers in the Indian market (1.72%).

Stability and Growth of Payments

Stable Dividend: VALIANTORG has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: VALIANTORG's dividend payments have increased, but the company has only paid a dividend for 5 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (9.3%), VALIANTORG's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: VALIANTORG is paying a dividend but the company has no free cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Arvind Chheda (63 yo)





Mr. Arvind Kanji Chheda has been a Managing Director at Valiant Organics Limited since April 20, 2019 and served as its Whole Time Director since February 16, 2005 and as Chief Finance Officer since July 0...

CEO Compensation Analysis

Compensation vs Market: Arvind's total compensation ($USD128.97K) is below average for companies of similar size in the Indian market ($USD193.44K).

Compensation vs Earnings: Arvind's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: VALIANTORG's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

Experienced Board: VALIANTORG's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: VALIANTORG insiders have sold more shares than they have bought in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Valiant Organics Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Valiant Organics Limited
  • Ticker: VALIANTORG
  • Exchange: NSEI
  • Founded: 1984
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Implied Market Cap: ₹16.804b
  • Shares outstanding: 27.15m
  • Website:

Number of Employees


  • Valiant Organics Limited
  • 109, Udyog Kshetra
  • 1st Floor
  • Mumbai
  • Maharashtra
  • 400080
  • India


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/05 00:00
Annual Earnings2022/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.